List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.5.3.1. For curative treatment |
Others observations: Other combinations that deliver the target doses required such as 153 mg or 200 mg (as hydrochloride) with 50 mg artesunate can be alternatives. |
PAHO Strategic Fund Medicine List | 2.7.2. Anti-malarial |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.5.3.1. For curative treatment |
Others observations: Other combinations that deliver the target doses required such as 153 mg or 200 mg (as hydrochloride) with 50 mg artesunate can be alternatives. |
PAHO Strategic Fund Medicine List | 2.7.2. Anti-malarial |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.5.3.1. For curative treatment |
Others observations: Other combinations that deliver the target doses required such as 153 mg or 200 mg (as hydrochloride) with 50 mg artesunate can be alternatives. |
PAHO Strategic Fund Medicine List | 2.7.2. Anti-malarial |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |